Life Science Integrates (LSI) brings together Senior Leaders from across the Life Sciences, including industry, academia, government and regulators; providing them with unique opportunities to be part of the conversations that set out the industry’s challenges and identify effective strategies and solutions.
Following the continued success of last year’s inaugural digital event, the 3rd Bio Integrates conference will be held on 20 May 2021. Bio Integrates is a unique opportunity to engage with top executives in biotech, CDMO, supply chain, and funding and investment. Addressing the needs of innovative companies developing the therapies of tomorrow, this one-day conference provides a unique forum to discuss the major challenges impacting the sector.
Dr. Karin Schmitt, CBO of Mogrify, will be on the ‘Growing Pains’ panel to discuss:
How, where, when and if to grow are decisions critical to the success of all biotech focused companies – spanning products to services. How do you plan, implement and adapt your growth strategy?
- Value creation through growth is an imperative for all companies. What strategies work best in the biotech world?
- Strategies invariably evolve over time. We will hear from companies that have pivoted from service to product – and vice versa. Is this by design or by necessity?
- Self-proclaimed serial entrepreneurs are abundant. Where are the serial scalers? Do they exist? Are they hidden? Are they tied up in longer-term projects?
- What tools and techniques exist to support the development of growth strategies? What works? Are they transferable?
Mogrify is applying its proprietary and award-winning platforms, MOGRIFY® and epiMOGRIFY, to generate the scalable source of functional cell types required to transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies for indications of high unmet clinical need in immuno-oncology, ophthalmology and other disease areas.